Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;32(1):32-8.
doi: 10.1007/s12288-015-0506-5. Epub 2015 Jan 20.

Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome

Sachin Punatar  1 , Alok Gupta  1 , Jayant Gawande  1 , Bhausaheb Bagal  1 , Libin Mathew  1 , Sadhana Kannan  2 , Navin Khattry  1
Affiliations

Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome

Sachin Punatar et al. Indian J Hematol Blood Transfus. 2016 Mar.

Abstract

Chronic graft versus host disease (cGVHD) is a common late complication of allogenic hematopoietic stem cell transplant (HSCT). We analyzed risk factors, pattern and long term transplant outcomes of cGVHD at a tertiary cancer centre. Seventy-seven consecutive patients who underwent HSCT for acute leukemia were included. Forty (52 %) patients developed cGVHD; 24 (60 %) extensive stage while 16 (40 %) limited stage. Oral cavity was the commonest site of involvement (25 patients) followed by liver, skin and lung. We found that female donor to male recipient transplant and diagnosis of acute lymphoblastic leukemia (ALL) were the only factors associated with increased risk of cGVHD. The incidence of leukemia relapse was 18 % in patients who developed cGVHD compared to 51 % in those who did not (P = 0.002). Four year overall survival and relapse free survival (RFS) were 62 and 46 % in patients who developed cGVHD compared to 29 % (P < 0.001) and 29 % (P < 0.001) in patients who did not develop cGVHD, respectively. We conclude that cGVHD is more common in male patients with female donors and in patients transplanted for ALL. Oral cavity is the commonest site of cGVHD in our patients and transplant related survival outcomes are superior in patients who develop cGVHD.

Keywords: Acute leukemia; Allogeneic stem cell transplantation; Chronic graft-versus-host disease; Outcome; Risk factors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Pattern of organ involvement in cGVHD
Fig. 2
Fig. 2
Comparison of overall survival (OS) between patients with and without cGVHD
Fig. 3
Fig. 3
Comparison of relapse free survival (RFS) between patients with and without cGVHD
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transpl. 2008;28:121–129. doi: 10.1038/sj.bmt.1703111. - DOI - PubMed
    1. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood. 2002;100:1192–1200. doi: 10.1182/blood-2001-11-0059. - DOI - PubMed
    1. Lee SJ, Vogelsang G, Flowers ME. Chronic Graft-versus-Host Disease. Biol Blood Marrow Transpl. 2003;9:215–233. doi: 10.1053/bbmt.2003.50026. - DOI - PubMed
    1. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood. 1990;75:2459–2464. - PubMed
    1. Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O, et al. Graft-versus-host disease following allogenic transplantation from HLA-identical sibling with anti thymocyte globulin-based reduced-intensity preparative regimen. Blood. 2003;102:470–476. doi: 10.1182/blood-2002-12-3629. - DOI - PubMed

LinkOut - more resources